جست‌وجوی استاد و پژوهشگر

• Environmental Health Engineering
• Wastewater-Based Epidemiology
• Bioremediation
• +۷ مورد دیگر

Rolf Halden is a Professor and Center Director at Arizona State University, holding appointments in the School of Sustainable Engineering and the Built Environment, the Biodesign Center for Environmental Health Engineering, and the Global Futures Scientists and Scholars program. He is a leading expert in environmental health engineering, wastewater-based epidemiology, and bioremediation. Education: Ph.D. in Civil (Environmental) Engineering, University of Minnesota (1997) M.S. in Civil (Environmental) Engineering, University of Minnesota (1994) M.S. in Biology, Technical University of Braunschweig, Germany (1992) Postdoctoral Fellow, Environmental Science, Lawrence Livermore National Laboratory (1998) Research Focus: Halden’s research integrates environmental chemistry, public health, and sustainability to understand how anthropogenic chemicals affect ecological and human health. His lab uses advanced mass spectrometry (LC-MS/MS, MALDI-TOF) to track pollutants such as PPCPs, microplastics, pesticides, and dioxins across air, water, soil, and biological systems. He pioneered the use of wastewater treatment plants as public health observatories, enabling real-time tracking of disease, drug use, and environmental exposures. Scientific Awards & Recognition: Leadership Award, Arizona State University (2018) Rocky Mountain Emmy Award (2018) Leroy E. Burney Lecturer, Johns Hopkins School of Public Health (2011) ACS Expert Program Member (2014–present) NIEHS Superfund R01 Working Group National Leader (2012–2014) Labs & Teams: Halden is the Founding Director of the Biodesign Center for Environmental Health Engineering at ASU, where he leads a multidisciplinary team focused on environmental proteomics, bioremediation, and diagnostic tool development. He also co-leads the Human Health Observatory , a national wastewater monitoring network. Grants & Funding: Halden has secured major funding from NSF, NIH, EPA, DoD, and private industry. Notable projects include the development of in-situ groundwater monitoring devices, national wastewater surveillance of SARS-CoV-2, and studies on microplastics and neurodegenerative disease.

• Biomarkers
• Stroke Research
• Proteomics
• +۷ مورد دیگر

Dr. Shubham Misra is a Research Fellow in the Department of Neurology at Yale University School of Medicine. He holds a Ph.D. in Neurology from the All India Institute of Medical Sciences (2022) and advanced degrees in Biotechnology from Amity University (2014). His research focuses on biomarker discovery, proteomics, and clinical data analysis in neurological disorders, particularly stroke and post-stroke epilepsy. Dr. Misra has authored over 50 peer-reviewed publications, including work in JAMA Neurology and Neurology , and leads research on omics-based approaches in stroke at Frontiers in Neurology. He collaborates globally, including with the WHO's Brain Health Unit to address neurological aspects of pandemics like COVID-19. Research Interests: Biomarker discovery using proteomics and machine learning, outcomes research in stroke, genetic risk factors for neurological disorders, and systematic reviews/meta-analyses. Dr. Misra's work bridges clinical neurology with advanced data science, aiming to improve diagnostics and patient outcomes. Awards: Young Investigator Award (World Stroke Organization), DST-INSPIRE Fellowship (India), and multiple international travel grants for collaborative research. Grants & Collaborations: Leads the International Post-stroke Epilepsy Research Repository (IPSERR) and collaborates with institutions worldwide. His work on post-stroke epilepsy and stroke subtyping biomarkers has been widely cited (over 1,200 citations). Labs & Teams: Mishra Lab at Yale, Rangaraju Lab, and global networks through the WHO's Global Forum and IPSERR consortium.

• Food Safety
• Food Chain Integrity
• Microbiological Risk Assessment
• +۶ مورد دیگر

Professor Francis Butler is a Full Professor at University College Dublin's School of Biosystems and Food Engineering, where he has been since 1990. His academic roles include research leadership in food safety, food chain integrity, and microbial risk assessment. He leads the UCD Institute for Food and Health and the UCD Centre for Food Safety as a Principal Investigator. Education: BE, Grad Dip University Teaching & Learning, MBA, and PhD from University College Dublin. Research Focus: His work centers on food safety hazards, quantitative risk assessment, and next-generation sequencing for pathogen identification. Recent projects include Listeria monocytogenes growth modeling, norovirus in oysters, and hepatitis E in pork products. He has secured over €6 million in research grants, including EU-funded projects like FOODINTEGRITY and SIGMACHAIN. Awards & Recognition: European Food Safety Authority Fellowship, Marie Sklodowska-Curie Fellowship, and UCD Teaching Grant. He coordinates international educational programs, including the UCD MSC Food Safety and Risk Analysis. Professional Activities: Member of EFSA advisory committees, editorial boards (e.g., Microbial Risk Analysis ), and international conference chairs. His work bridges academia, industry, and policy to enhance food safety standards globally.

Lars E. Erikssonمشاهده پروفایل

استاد

• Translational Nursing Research
• Biobehavioral Nursing
• Quality of Life
• +۹ مورد دیگر

Professor Lars E. Eriksson is a Registered Nurse with a PhD in Nursing and an MSc in Chemistry, currently serving as a part-time Professor in Nursing at the School of Health and Medical Sciences, City St George's, University of London, and as a full Professor in Nursing at Karolinska Institutet, Stockholm, Sweden, where he leads the Lars E. Eriksson Research Group. His academic journey began with a UC in Nursing in 1985, followed by over a decade of clinical work in hematology, immunology, and HIV care in Stockholm, before transitioning into research and academia. His research is centered on biobehavioral and translational nursing, particularly focusing on health and quality of life among individuals with chronic conditions such as HIV, cancer, and long-term infections. Key areas include disease-related stigma, symptom research, patient-reported outcomes, and biomarker development. He is Principal Investigator for a lung cancer biomarker project funded by the Swedish Research Council and the Swedish PI for the H2020 Magnet4Europe project on mental health in healthcare workplaces. His recent publications show a strong trend in using mixed methods to explore end-of-life communication, death literacy, sexual and reproductive health after cancer, and stigma in chronic illness. He frequently employs patient-reported outcomes, online focus groups, and web-based interventions, often in collaboration with international partners. His work bridges clinical practice, nursing science, and public health. Scientific Awards and Memberships: British HIV Association (BHIVA) National HIV Nurses Association (NHIVNA) Swedish Society of Nursing Swedish Society of Medicine Swedish Society of Medical Microbiology Lars Eriksson has advised numerous PhD and Master’s students, primarily on topics related to quality of life, stigma, and chronic illness. He teaches postgraduate modules including MSc Dissertation, Advanced Practice Dissertation, and Sexual and Reproductive Health. He is affiliated with the Centre for Health Services Research and the Centre for Public Health Research at City St George's.

Pilar Pérez Romeroمشاهده پروفایل

دانشیار

• Virology
• Immunology
• Infectious Diseases
• +۱۲ مورد دیگر

Pilar Pérez Romero is an Associate Professor in the Department of Biological Sciences at the University of Notre Dame, where she leads research on human cytomegalovirus (CMV) and host immune interactions. She has previously held academic positions at the National Centre for Microbiology in Madrid and the Biomedical Institute of Seville, Spain. Her research interests include: Virology and molecular mechanisms of CMV infection Virus-host interactions and immune evasion CMV-specific T-cell and neutralizing antibody responses Immunotherapy and vaccine design for CMV Applications in solid organ transplant recipients and congenital infection Her recent publications show a strong focus on CMV immunopathogenesis, with increasing emphasis on translational applications such as monoclonal antibody therapies, adoptive T-cell transfer, and vaccine development. She frequently employs transcriptomic and proteomic methods and collaborates on clinical studies involving transplant patients. Her scientific contributions include: Characterization of CMV antigens inducing protective immunity Identification of novel viral gene products involved in immune regulation Development of methods for CMV gene deletion and functional studies Contributions to clinical guidelines for CMV management in transplantation Dr. Pérez Romero advises research students and collaborates with multidisciplinary teams, including immunologists, virologists, and clinicians. Her work is supported by institutional and collaborative research funding, with potential applications in antiviral therapies and vaccinology. She leads a research laboratory focused on viral immunology and pathogenesis at Notre Dame.

Jörg Schultzمشاهده پروفایل

استاد

• Bioinformatics
• Computational Biology
• Evolutionary Genomics
• +۵ مورد دیگر

Prof. Dr. Jörg Schultz serves as a Professor for Bioinformatics at the Faculty of Biology, University of Würzburg, a position he has held since 2003. He is also a Group Leader at the Center for Computational and Theoretical Biology (CCTB) and was a member of the CCTB Managing Board from 2015-2019. His academic journey includes significant roles as Group Leader at the Max Planck Institute for Molecular Genetics in Berlin (2002-2003) and at cellzome in Heidelberg (2000-2002). He completed his PhD studies at EMBL Heidelberg (1996-2000) after conducting his diploma thesis there in 1995-1996, following biology studies at the University of Konstanz (1991-1996). Prof. Schultz's research spans bioinformatics, computational biology, and evolutionary genomics, with notable contributions to protein domain analysis, phylogenetics, and structural bioinformatics. His recent work has focused extensively on plant genomics, particularly studying carnivorous plants like the Venus flytrap to uncover the evolutionary roots of plant carnivory. His research integrates computational methods with biological questions to address fundamental evolutionary patterns and molecular mechanisms across diverse organisms. Prof. Schultz has maintained a prolific publication record since the late 1990s, with his most recent work demonstrating continued innovation in computational approaches to biological questions. His publications reveal a consistent trajectory from foundational work on protein domain evolution (including the development of the SMART database) to current research on plant genomics, molecular evolution, and bioinformatics tool development. His work shows particular strength in bridging computational methodology with biological insight across multiple domains. Among his significant contributions is the development of the ITS2 Database, a widely used resource for phylogenetic analyses, along with various computational tools including ALVIS for sequence alignment visualization, reper for repetitive element analysis, and BCdatabaser for DNA barcoding. These resources have advanced methodological capabilities in the bioinformatics community. As an academic mentor, Prof. Schultz has guided numerous students and researchers through his laboratory at the University of Würzburg, contributing significantly to the education and training of the next generation of bioinformaticians. His leadership roles demonstrate his commitment to advancing computational and theoretical biology as academic disciplines while maintaining strong connections between computational approaches and biological discovery.

• Extracellular Vesicles
• Biomarker Discovery
• Exosome Biology
• +۷ مورد دیگر

Carlos Salomon Gallo is a Professor and NHMRC Investigator Fellow (EL2) at The University of Queensland's Centre for Clinical Research, affiliated with the School of Biomedical Sciences. He directs the Centre for Extracellular Vesicle Nanomedicine and leads the Exosome Biology Laboratory. A globally recognized key opinion leader in extracellular vesicles (ranked 3rd worldwide by Expertscape), his research focuses on EV biology for diagnostic and therapeutic applications in ovarian cancer, gestational diabetes, preeclampsia, and other obstetrical syndromes. His research integrates proteomics (SWATH-MS), miRNA analysis, and advanced isolation techniques to develop liquid biopsies. Core interests include: EV biomarker discovery and validation for early disease detection. Mechanisms of EV-mediated signaling in metabolic and oncological pathologies. Engineering EVs for targeted drug delivery and CRISPR-Cas therapeutics. Clinical translation of EV-based diagnostics (IVDs) and therapeutics. Analysis of his recent articles reveals a dominant focus on EV profiling in pregnancy complications (gestational diabetes, preeclampsia) and oncology (ovarian cancer), utilizing multi-omics approaches. Key trends include developing high-sensitivity EV biosensors, understanding hypoxia-induced EV signaling, and exploring 3D models for EV research. He has received significant recognition, including: NHMRC Emerging Leadership Fellow NHMRC Investigator Fellow (EL2) He leads the Exosome Biology Laboratory and the UQ Centre for Extracellular Vesicle Nanomedicine, fostering cross-disciplinary collaboration. His work involves extensive national and international partnerships, evidenced by leadership roles in the Centre for Clinical Diagnostics and over 20 invited international talks in 5 years. He actively mentors HDR students and contributes to global EV research standards (MISEV2023).

Craig Russellمشاهده پروفایل

مدرس

• Pharmaceutical Formulation
• Drug Delivery Systems
• Nanotechnology in Pharmacy
• +۳ مورد دیگر

Craig Russell is a Lecturer in Pharmacy at Aston University, affiliated with the College of Health and Life Sciences and the Pharmaceutical & Clinical Pharmacy Research Group. He holds a PhD in Paediatric Drug Development from Aston University (2014) and a BSc in Human Biology from the University of Huddersfield (2010). His research focuses on pharmaceutical formulation design, 3D printing in drug manufacturing, nanoparticle drug delivery systems, and genomic approaches to drug development. He leads the MPharm Programme and teaches across multiple disciplines, including Cell Biology, Formulation Science, and Biopharmaceutics. Key projects include a funded PhD investigating 3D printing in tablet production (2018) and collaborations with major pharmaceutical companies like AstraZeneca and GSK. His work emphasizes translational research, bridging laboratory innovations with clinical applications. Recent studies explore mesoporous silica microparticles for targeted drug delivery and photopolymer resin optimization for Stereolithography. Education: BSc Human Biology (Huddersfield, 2010), PhD in Paediatric Drug Development (Aston, 2014), PG Cert HEA (2018). Teaching: MPharm Programme Director; lectures on Cell Biology, Immunology, and Formulation Science. Research Themes: Pharmaceutical Formulation, Nanotechnology, 3D Printing, Genomics. Grants: Internal funding for 3D printing in tablet production. Collaborations: AstraZeneca, GSK, Pfizer, Bristol Myers Squibb, UCL. His articles span drug delivery systems, 3D printing advancements, and genomic profiling, reflecting a commitment to innovation in pharmaceutical science.

Premdass Ramdasمشاهده پروفایل

مدرس ارشد

• Cancer Cell Biology
• Quantitative Proteomics
• Genomics
• +۱۲ مورد دیگر

Dr. Premdass Ramdas is a Senior Lecturer at Monash University Malaysia, affiliated with the Jeffrey Cheah School of Medicine and Health Sciences. He joined in October 2023 with over 13 years of experience in medical biotechnology and health sciences, focusing on cancer research and bioactive natural compounds. PhD in Cancer Proteomics and Genomics, University of Malaya MSc in Medical Sciences (Cancer Genomics and Natural Products), International Medical University BSc with First-Class Honors His research focuses on the anticancer mechanisms of tocotrienols, utilizing proteomics, genomics, bioinformatics, and mouse models. He explores epigenetics, nutrigenomics, RNA/microRNA analysis, exosome biology, and AI-driven big data in cancer. His work contributes to UN Sustainable Development Goals in health and well-being. Recent publications show a strong trend in systematic reviews and mechanistic studies on vitamin E analogues in cancer, particularly colorectal and breast cancers. His research integrates molecular biology with computational approaches, including molecular docking and data mining. First-class honors for BSc Malaysian Palm Oil Board Scholarship for MSc MyBrain15 Scholarship for PhD Dr. Ramdas has secured research grants such as FRGS and actively supervises research projects. He is currently accepting PhD students and has co-supervised non-HDR reviews, indicating active mentorship. He has no known labs or teams explicitly mentioned, but collaborates extensively, particularly with Prof. Radhakrishnan A.K.

Elizabeth A. Edwardsمشاهده پروفایل

استاد

• Bioremediation
• Environmental Biotechnology
• Anaerobic Microbial Processes
• +۳ مورد دیگر

Elizabeth A. Edwards is a University Professor at the University of Toronto in the Department of Chemical Engineering and Applied Chemistry , with cross-appointments to the Department of Cell & Systems Biology . As Director of BioZone and Canada Research Chair in Anaerobic Biotechnology, she leads groundbreaking research in microbial bioremediation of groundwater pollutants and industrial wastewater treatment through anaerobic digestion. Ph.D. in Environmental Engineering (Stanford, 1993) M.Eng. and B.Eng. in Chemical Engineering (McGill, 1985/1983) Licensed Professional Engineer (P.Eng.) Her research focuses on anaerobic microbial communities that degrade pollutants like chlorinated solvents and aromatic hydrocarbons. Using advanced molecular biology, genomics, proteomics , and biochemical pathway analysis , her lab investigates functional interactions in microbial consortia and translates discoveries to commercial applications such as the KB-1® bioproduct . Recent studies examine enzyme activity, lignocellulose degradation, and granulation dynamics in anaerobic reactors. Scientific Recognition: 2020 Killam Prize in Engineering 2016 Canada Research Chair (Tier 1) 2014 Royal Society of Canada Fellow 2011 Canadian Academy of Engineering Fellow 2011 AAAS Fellow 2008-2010 Killam Research Fellowship She supervises extensive graduate student projects spanning enzyme discovery, bioremediation optimization, and microbial consortium analysis. Her lab collaborates with GeoSyntec Consultants and SiREM Labs for field implementation of bioremediation strategies.

Mariana Saمشاهده پروفایل

دانشیار

• Fungal Biology
• Taxonomy
• Proteomics
• +۴ مورد دیگر

Dr. Mariana Sa serves as an Associate Professor of Biology at Belhaven University, where she has been a faculty member since 2025. Her research focuses on fungal biodiversity with specialization in taxonomy, systematics, and proteomics, contributing significantly to the understanding of Neotropical mycobiota through extensive fieldwork in Brazilian ecosystems including the Amazon, Atlantic Forest, and caatinga regions. Her academic credentials include: Ph.D. in Biological Sciences from the Federal University of Rio Grande do Norte M.S. in Biological Sciences from the Federal University of Rio Grande do Norte B.S. in Biological Sciences from the Federal University of Paraiba She further developed her expertise through postdoctoral fellowships at Mackenzie Presbyterian University and the University of Guelph in Canada. Dr. Sa's research program integrates morphological, molecular, and biochemical approaches to explore fungal diversity. She specializes in describing new species and elucidating phylogenetic relationships within Basidiomycota, particularly Russulaceae and related families. Her work bridges classical taxonomy with modern proteomic techniques to understand fungal evolution and ecological adaptations in understudied tropical and semiarid habitats. This interdisciplinary approach has positioned her as a leading contributor to Brazilian mycology. Analysis of her publication record reveals consistent contributions to fungal systematics over the past decade, with particular emphasis on discovering novel taxa from ecologically diverse Brazilian biomes. Her research demonstrates a clear trajectory of increasing taxonomic sophistication, incorporating molecular phylogenetics alongside traditional morphological characterization to resolve complex classification problems in groups like Lactifluus and Russula. Her professional experience includes seven years of teaching at the University Center of João Pessoa, where she instructed courses in cellular and molecular biology, biochemistry, microbiology, immunology, and genetics prior to joining Belhaven University. While the provided information does not specify current advisees or research grants, her extensive publication record suggests active mentorship of students in research activities.

Ruan Elliottمشاهده پروفایل

مدرس ارشد

• Nutritional Metabolism
• DNA Damage and Repair
• Nutrigenomics
• +۴ مورد دیگر

Dr Ruan Elliott is Dean of the Doctoral College and Senior Lecturer in Nutrition at the University of Surrey's School of Biosciences. He holds a PhD in Nutritional Metabolism (2017) and BA in Natural Sciences from Cambridge (1988). His research focuses on nutritional modulation of DNA repair mechanisms, functional genomics in nutrigenomics, and micronutrient homeostasis of iron, copper, selenium, and zinc. He has led studies on vitamin D efficacy, food bioavailability, and oxidative stress biomarkers. Education: PhD (University of Surrey, 1992), BA (University of Cambridge, 1988) Previous Roles: Senior Scientist (Institute of Food Research, 1994-2009), Postdoctoral Fellow (University of British Columbia, 1992-1994) His research integrates molecular biology and nutrition to address health impacts of dietary components. Recent work explores oat-based milk alternatives' sensory profiles, vitamin D supplementation efficacy, and DNA repair pathways in cardiovascular disease. He collaborates internationally on projects like the D2-D3 Study and NuGO initiatives. Publications emphasize translational research, including systematic reviews on insect protein efficacy and meta-analyses of vitamin D supplementation. His work bridges lab-based models (e.g., Caco-2 cells for iron studies) and clinical applications. No scientific awards were explicitly listed in the provided texts. He advises on doctoral training programs and has contributed to grant-funded projects like the University of Surrey's food and infection biosciences initiative (2024). Collaborations include studies on probiotics' immune effects and transcriptomic analysis of metabolic conditions.

Evelina Charidemouمشاهده پروفایل

استادیار

• Nutritional Biochemistry
• Metabolism
• Metabolomics
• +۷ مورد دیگر

Dr. Evelina Charidemou is an Assistant Professor at the Department of Life Sciences, School of Life and Health Sciences, University of Cyprus. She holds a PhD in Biochemistry from the University of Cambridge and a Bachelor's degree (Honors) from Imperial College London, where she earned the Royal College of Science Associateship (ARCS). Her research focuses on developing metabolomics and lipidomics tools to investigate metabolic syndrome, particularly Type II diabetes and non-alcoholic fatty liver disease, using high-performance liquid chromatography and multivariate bioinformatics. Specialties: Nutritional Biochemistry, Metabolism, Histone Acetylation Collaborations: University of Oxford, University of Aarhus, Imperial College London Leadership: President of Cyprus Metabolomic Network Key Awards: Marie Skłodowska-Curie Individual Fellowship, Best Presentation (Metabolomics Sardinian Scientific School) Her work has been published in high-impact journals including Trends in Biochemical Sciences , EMBO Journal , and Hepatology , with a focus on the interplay between epigenetic mechanisms and metabolic diseases. She actively presents at international conferences such as the Metabolomics Society meetings and contributes to the International Journal of Biochemistry and Cell Biology.

Stephen Robinsonمشاهده پروفایل

مدرس

• Angiogenesis
• Cancer Biology
• Endothelial Cell Biology
• +۳ مورد دیگر

Stephen Robinson is a Lecturer in Cell Signalling and Angiogenesis at the University of East Anglia's School of Biological Sciences. He is affiliated with the Norwich Institute for Healthy Aging and Cells and Tissues research group. His work focuses on understanding the molecular mechanisms of angiogenesis and its role in cancer and aging. Education: PhD in Molecular Biology (1993, UC Santa Cruz), followed by postdoctoral research at MIT (1993-2000) and Cancer Research UK (2000-2011). He has led independent research at UEA since 2011. Research interests include alphaVbeta3-integrin regulation in angiogenesis, endothelial-pericyte interactions, and microbiota influences on breast cancer progression. Current projects aim to develop novel therapeutic targets for angiogenesis modulation. Grants include Mrs Doggett Cancer Research Donation (2018-2026) and Breast Cancer Now funding (2018-2022). He collaborates internationally on microbiome and cancer studies. Teaching includes modules on Cancer Biology (3C27) and Frontiers in Molecular Medicine (M201). His lab (www.therobinsonlab.co.uk) explores vascular biology and translational therapeutics.

Vernon Chinchilliمشاهده پروفایل

استاد

• Biostatistics
• Clinical Trials
• Multivariate Analysis
• +۴ مورد دیگر

Vernon M. Chinchilli is a Distinguished Professor of Public Health Sciences and Professor of Statistics at The Pennsylvania State University. He holds appointments in the Department of Public Health Sciences (Division of Biostatistics and Bioinformatics) and the Department of Statistics. His primary affiliation is with the College of Medicine. Dr. Chinchilli received his PhD in Statistics from the University of North Carolina at Chapel Hill (1979) and a BS in Mathematics from Penn State (1974). His research focuses on biostatistical methodology for multi-center clinical trials, multivariate analysis of longitudinal data, and statistical methods for crossover designs. He has led NIH-funded Data Coordinating Centers for studies on lung disease, kidney disease, and acute kidney injury (AKI). Notable roles include Principal Investigator for the Natural History of AKI Consortium and the Biostatistics Research Center for Impaired Awareness of Hypoglycemia. Dr. Chinchilli teaches doctoral courses in multivariate analysis (PHS 523) and statistical methods in public health (PHS 554/555). He has advised 35 PhD and 40 MS students. His honors include Fellow of the American Statistical Association (1997) and extensive contributions to methodological advancements in clinical trial design and analysis. Key areas of investigation include: 1) statistical methods for agreement assessment and equivalence testing in clinical trials, 2) biomarker development for kidney function decline, and 3) application of machine learning in predicting post-hospitalization outcomes. He collaborates internationally on projects like the ENICTO cancer treatment outcomes initiative and the S-AKI sepsis biomarker study. Recent work explores: cognitive change measurement in aging populations, opioid alternative therapies for chronic pain, and vaccine efficacy in immunocompromised patients. His research spans 541 peer-reviewed publications and 15 active NIH grants, with particular emphasis on translating statistical innovations into clinical practice.